Biotech

All Articles

Boundless Bio makes 'reasonable' discharges five months after $100M IPO

.Merely 5 months after safeguarding a $100 million IPO, Boundless Bio is already laying off some sta...

Halda's $126M will definitely evolve 'keep as well as get rid of' cyst medications

.The first stages of oncology R&ampD aren't short of interesting new methods, as well as Halda Thera...

Lykos 'regrets' certainly not divulging research violations along with author

.Psychopharmacology has actually drawn three articles about midstage medical trial records analyzing...

Analysts dig into Avidity's DMD win, uncovering distinctions in data

.Avidity Biosciences satisfied investors along with stage 1/2 records in Duchenne muscular dystrophy...

Actinogen's cortisol blocker fails stage 2 depression research

.Actinogen Medical's cortisol blocker has actually skipped the key endpoint of a period 2 research i...

Bivictrix makes a decision going exclusive only way to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have been at the facility of lots of a billion-dollar biobuck licen...

TPG leadings up funds to $580M for assets across lifestyle scientific researches

.Possession supervisor TPG, which has sustained biotechs like Sionna Therapies and also Santa Ana Bi...

Merck stops period 3 TIGIT trial in bronchi cancer for impossibility

.Merck &amp Co.'s TIGIT plan has actually gone through an additional problem. Months after shutterin...

After a challenging year, Exscientia folds in to Recursion

.After a year described through pipe hairstyles, the shift of its chief executive officer and also l...

Cullinan, after $25M package, restore bispecific to Harbour

.Cullinan Therapy was actually blown away good enough along with Port BioMed's bispecific invulnerab...